Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial.

Thomas ZeyenAnna-Laura PotthoffRobert NemethDieter H HeilandMichael C BurgerJoachim P SteinbachPeter HauGhazaleh TabatabaiMartin GlasUwe SchlegelOliver GrauerDietmar KrexOliver SchnellRoland GoldbrunnerMichael SabelNiklas ThonDaniel DelevHans ClusmannClemens SeidelErdem GüresirMatthias SchmidPatrick SchussFrank A GiordanoAlexander RadbruchAlbert BeckerJohannes WellerChristina SchaubHartmut VatterJudith SchillingFrank WinklerUlrich HerrlingerMatthias Schneider

Published in: Trials (2022)

EudraCT 2021-000708-39 . Registered on 08 February 2021.

Keyphrases

phase iii
study protocol
phase ii
clinical trial
multiple sclerosis
randomized controlled trial
open label
stem cells
cell therapy
smoking cessation